Wu Kailiang

Currently serving as Assistant to the President and Director of the Department of Thoracic Oncology at Shanghai Proton and Heavy Ion Center, and Chief Physician of the Department of Radiation Oncology at Fudan University Cancer Hospital. Standing Committee Member of the Mediastinal Tumor Committee of the Chinese Anti-Cancer Association, Deputy Leader of the Preparatory Group of the Ion Radiotherapy Branch of the China Medical Equipment Association, Deputy Director of the Lung Cancer Targeted and Immunotherapy Committee of the Shanghai Anti-Cancer Association, and Member of the Lung Cancer Group of the Tumor Radiotherapy Committee of the Chinese Anti-Cancer Association. From May 2007 to August 2009, he conducted postdoctoral research at the Sunnybrook Health Sciences Centre, University of Toronto. He has long been engaged in clinical and basic research on thoracic tumors such as lung cancer, mediastinal tumors, and esophageal cancer, and has extensive experience in thoracic tumor radiotherapy. He has published over 80 papers, including 35 SCI papers with a total impact factor of 160; among them, 25 are SCI papers as first or corresponding author, with the highest single SCI impact factor being 7.02. He is the chief editor of the monographs "Clinical Oncology Radiotherapy" and "Practical Thoracic Tumor Radiotherapy," and has participated in the writing of more than 10 monographs. He has obtained three personal patents.